| |
| |
|
| Insider
Information: |
Berger Harvey J MD |
| Relationship: |
Chairman & CEO, Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,732,111 |
|
|
Indirect Shares
|
2,604,336 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
4,336,447 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
Chairman & CEO, Director |
2015-12-31 |
1,732,111 |
2015-12-31 |
2,604,336 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
99 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-10-16 |
4 |
AB |
$5.39 |
$67,318 |
I/I |
12,500 |
1,764,286 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-11-19 |
4 |
AB |
$6.15 |
$76,853 |
I/I |
12,500 |
1,776,786 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-11-20 |
4 |
AB |
$6.15 |
$76,889 |
I/I |
12,500 |
1,789,286 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-12-17 |
4 |
AB |
$6.15 |
$76,875 |
I/I |
12,500 |
1,801,786 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-12-18 |
4 |
AB |
$6.54 |
$81,770 |
I/I |
12,500 |
1,814,286 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-01-22 |
4 |
AB |
$6.16 |
$76,990 |
I/I |
12,500 |
1,826,786 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-01-23 |
4 |
AB |
$6.18 |
$77,250 |
I/I |
12,500 |
1,839,286 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-02-11 |
4 |
AB |
$6.77 |
$84,569 |
I/I |
12,500 |
1,851,786 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-02-12 |
4 |
AB |
$6.90 |
$86,280 |
I/I |
12,500 |
1,864,286 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2008-05-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
13,434 |
4,478 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-04-01 |
4 |
D |
$8.52 |
$115,736 |
D/D |
(13,584) |
1,129,324 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$86,647 |
D/D |
(15,556) |
1,122,621 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-20 |
4 |
D |
$20.45 |
$328,529 |
D/D |
(16,065) |
1,694,024 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-07-15 |
4 |
D |
$8.35 |
$145,040 |
D/D |
(17,370) |
1,366,492 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2008-05-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
17,912 |
90,015 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-04-01 |
4 |
D |
$18.30 |
$360,290 |
D/D |
(19,688) |
1,767,521 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2011-07-26 |
4 |
OE |
$4.80 |
$100,018 |
D/D |
20,837 |
1,938,136 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2006-03-10 |
4 |
OE |
$4.19 |
$92,180 |
D/D |
22,000 |
352,963 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2012-06-13 |
4 |
OE |
$4.05 |
$99,999 |
D/D |
24,691 |
2,195,638 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2012-12-18 |
4 |
D |
$20.18 |
$526,577 |
D/D |
(26,094) |
2,226,089 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-12-18 |
4 |
D |
$4.98 |
$146,910 |
D/D |
(29,500) |
1,050,759 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2009-01-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
32,772 |
15,402 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,000 |
1,710,089 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,000 |
1,109,048 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,000 |
1,320,654 |
0 |
- |
|
99 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
